Longboard Pharmaceuticals, Inc. financial data

Location
La Jolla, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2024 - 07 Nov 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1835% % 106%
Return On Equity -33% % 60%
Return On Assets -31% % 58%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 39,045,703 shares 64%
Common Stock, Shares, Outstanding 34,419,536 shares 61%
Common Stock, Value, Issued $3,000 USD 50%
Weighted Average Number of Shares Outstanding, Basic 38,957,524 shares 66%
Weighted Average Number of Shares Outstanding, Diluted 38,957,524 shares 66%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $67,263,000 USD 65%
General and Administrative Expense $20,187,000 USD 66%
Operating Income (Loss) $87,450,000 USD -65%
Net Income (Loss) Attributable to Parent $76,344,000 USD -50%
Earnings Per Share, Basic -2 USD/shares 7.1%
Earnings Per Share, Diluted -2 USD/shares 7.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $27,610,000 USD 15%
Cash, Cash Equivalents, and Short-term Investments $288,400,000 USD 415%
Assets, Current $293,030,000 USD 402%
Other Long-term Investments $244,000 USD 578%
Property, Plant and Equipment, Net $0 USD -100%
Operating Lease, Right-of-Use Asset $3,731,000 USD 646%
Assets $297,005,000 USD 405%
Accounts Payable, Current $1,132,000 USD 212%
Accrued Liabilities, Current $1,894,000 USD 291%
Liabilities, Current $18,352,000 USD 173%
Operating Lease, Liability, Noncurrent $3,467,000 USD 3110%
Accumulated Other Comprehensive Income (Loss), Net of Tax $700,000 USD
Retained Earnings (Accumulated Deficit) $201,875,000 USD -61%
Stockholders' Equity Attributable to Parent $275,186,000 USD 429%
Liabilities and Equity $297,005,000 USD 405%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $15,177,000 USD -16%
Net Cash Provided by (Used in) Financing Activities $286,404,000 USD 1241%
Net Cash Provided by (Used in) Investing Activities $230,919,000 USD -3896%
Common Stock, Shares Authorized 300,000,000 shares 0%
Common Stock, Shares, Issued 34,419,536 shares 61%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $40,308,000 USD 181%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $27,854,000 USD 16%
Operating Lease, Liability $3,734,000 USD 644%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $75,463,000 USD -51%
Lessee, Operating Lease, Liability, to be Paid $5,102,000 USD 859%
Operating Lease, Liability, Current $267,000 USD -32%
Lessee, Operating Lease, Liability, to be Paid, Year Two $785,000 USD 84%
Lessee, Operating Lease, Liability, to be Paid, Year One $662,000 USD 530%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,368,000 USD 4460%
Lessee, Operating Lease, Liability, to be Paid, Year Three $820,000 USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $856,000 USD
Operating Lease, Payments $105,000 USD 12%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $1,000 USD 0%
Share-based Payment Arrangement, Expense $8,794,000 USD 195%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%